Varenhorst E, Björnlert U, Carlström K
Scand J Urol Nephrol. 1981;15(2):157-9. doi: 10.3109/00365598109179594.
An 80-year-old man with advanced adenocarcinoma of the prostate received cyproterone acetate, 200 mg orally per day as sole treatment. Striking regression of the tumour was demonstrated by ultrasonograms and excretory urograms. Serum concentrations of acid phosphatases, gonadotrophins, and testosterone decreased significantly. No significant cardiovascular side effects occurred.
一名80岁晚期前列腺腺癌男性患者，仅接受每天口服200毫克醋酸环丙孕酮的治疗。超声检查和排泄性尿路造影显示肿瘤显著消退。酸性磷酸酶、促性腺激素和睾酮的血清浓度显著下降。未出现明显的心血管副作用。
